You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

FLUOXETINE HYDROCHLORIDE; OLANZAPINE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for fluoxetine hydrochloride; olanzapine and what is the scope of patent protection?

Fluoxetine hydrochloride; olanzapine is the generic ingredient in two branded drugs marketed by Endo Operations, Epic Pharma Llc, Teva Pharms, and Lilly, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

Four suppliers are listed for this compound.

Summary for FLUOXETINE HYDROCHLORIDE; OLANZAPINE
Recent Clinical Trials for FLUOXETINE HYDROCHLORIDE; OLANZAPINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Second Xiangya Hospital of Central South UniversityPhase 1/Phase 2
First Affiliated Hospital of Chongqing Medical UniversityPhase 1/Phase 2
First Affiliated Hospital of Zhejiang UniversityPhase 4

See all FLUOXETINE HYDROCHLORIDE; OLANZAPINE clinical trials

Pharmacology for FLUOXETINE HYDROCHLORIDE; OLANZAPINE
Paragraph IV (Patent) Challenges for FLUOXETINE HYDROCHLORIDE; OLANZAPINE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
SYMBYAX Capsules fluoxetine hydrochloride; olanzapine 6 mg/25 mg 12 mg/25 mg 6 mg/50 mg 12 mg/50 mg 021520 1 2005-01-10

US Patents and Regulatory Information for FLUOXETINE HYDROCHLORIDE; OLANZAPINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Epic Pharma Llc OLANZAPINE AND FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride; olanzapine CAPSULE;ORAL 078901-004 Nov 16, 2012 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Epic Pharma Llc OLANZAPINE AND FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride; olanzapine CAPSULE;ORAL 078901-002 Nov 16, 2012 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Epic Pharma Llc OLANZAPINE AND FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride; olanzapine CAPSULE;ORAL 078901-005 Nov 16, 2012 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Epic Pharma Llc OLANZAPINE AND FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride; olanzapine CAPSULE;ORAL 078901-003 Nov 16, 2012 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Endo Operations OLANZAPINE AND FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride; olanzapine CAPSULE;ORAL 077742-002 Nov 2, 2012 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lilly SYMBYAX fluoxetine hydrochloride; olanzapine CAPSULE;ORAL 021520-003 Dec 24, 2003 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for FLUOXETINE HYDROCHLORIDE; OLANZAPINE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lilly SYMBYAX fluoxetine hydrochloride; olanzapine CAPSULE;ORAL 021520-005 Dec 24, 2003 ⤷  Sign Up ⤷  Sign Up
Lilly SYMBYAX fluoxetine hydrochloride; olanzapine CAPSULE;ORAL 021520-003 Dec 24, 2003 ⤷  Sign Up ⤷  Sign Up
Lilly SYMBYAX fluoxetine hydrochloride; olanzapine CAPSULE;ORAL 021520-001 Apr 9, 2007 ⤷  Sign Up ⤷  Sign Up
Lilly SYMBYAX fluoxetine hydrochloride; olanzapine CAPSULE;ORAL 021520-002 Dec 24, 2003 ⤷  Sign Up ⤷  Sign Up
Lilly SYMBYAX fluoxetine hydrochloride; olanzapine CAPSULE;ORAL 021520-002 Dec 24, 2003 ⤷  Sign Up ⤷  Sign Up
Lilly SYMBYAX fluoxetine hydrochloride; olanzapine CAPSULE;ORAL 021520-004 Dec 24, 2003 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.